Abstract:There is a significant need for scalable CRISPR-based genetic screening methods that can be applied directly in mammalian tissues in vivo while enabling cell type-specific analysis. To address this, we developed an adeno-associated virus (AAV)-based CRISPR screening platform, CrAAVe-seq, that incorporates a Cre-sensitive sgRNA construct for pooled screening within targeted cell populations in the mouse tissues. We demonstrate the utility of this approach by screening two distinct large sgRNA libraries, together targeting over 5,000 genes, in mouse brains to create a robust profile of neuron-essential genes. We validate two genes as strongly neuron-essential in both primary mouse neurons and in vivo, confirming the predictive power of our platform. By comparing results from individual mice and across different cell populations, we highlight the reproducibility and scalability of the platform and show that it is highly sensitive even for screening smaller neuronal subpopulations. We systematically characterize the impact of sgRNA library size, mouse cohort size, the size of the targeted cell population, viral titer, and multiplicity of infection on screen performance to establish general guidelines for large-scale in vivo screens.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a highly scalable, cell - type - specific in - vivo CRISPR screening platform for direct application in mammalian tissues, especially for large - scale gene function studies in the mouse brain. Specifically, the researchers developed a CRISPR screening platform based on adeno - associated virus (AAV) - CrAAVe - seq. This platform can perform pooled screening in the target cell population by using Cre - sensitive sgRNA constructs. ### Main problems and solutions: 1. **Limitations of existing technologies**: - Most CRISPR screenings are carried out in cultured cells, and these methods cannot fully reproduce the physiological environment of multicellular organisms or tissues, especially states related to aging, inflammation or disease. - Especially in the study of complex organs such as the brain, the spatial interactions between cells are very complex, and existing in - vitro screening methods are difficult to capture these details. 2. **Advantages of the CrAAVe - seq platform**: - **Cell - type - specificity**: By introducing Cre recombinase - sensitive elements into the sgRNA constructs, CrAAVe - seq can selectively evaluate gene perturbation phenotypes in specific cell types. - **High - throughput and low - cost**: By using the extensive brain - transduction ability of AAV viral vectors and the method of amplifying sgRNA sequences from AAV episomes, the throughput and cost - effectiveness of screening are greatly improved. - **High - sensitivity**: Even in smaller neuronal subpopulations, CrAAVe - seq can detect important gene changes. 3. **Experimental verification**: - The researchers used two large - scale sgRNA libraries (containing approximately 12,000 and 18,000 sgRNA respectively) to carry out large - scale gene screenings in the mouse brain and successfully identified multiple genes that are crucial for neuronal survival. - By comparing the results of different mice and different cell populations, the reproducibility and high - sensitivity of this platform were proved. 4. **Application prospects**: - CrAAVe - seq is not only suitable for the study of neurons, but can also be extended to other cell types and tissues, providing a powerful tool for biological and medical research. ### Summary: This paper solves the limitations of existing CRISPR screening methods in in - vivo applications by developing the CrAAVe - seq platform, and provides an efficient, economical and highly - sensitive tool for gene function research, especially suitable for cell - type - specific research in complex organs such as the brain.

CRISPR screening by AAV episome-sequencing (CrAAVe-seq) is a highly scalable cell type-specific in vivo screening platform

Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain

Adeno-associated virus genome quantification with amplification-free CRISPR-Cas12a

Identification of &Lt;i>cis</i>-Regulatory Modules for Aav-Based Cell Type-Specific Targeting in the Retina and Brain

CRISPR-StAR enables high-resolution genetic screening in complex in vivo models

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

CRISPR screen for rAAV production implicates genes associated with infection

CASAAV: A CRISPR‐Based Platform for Rapid Dissection of Gene Function in Vivo

Identifying adeno-associated virus (AAV) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses

In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening

High levels of AAV vector integration into CRISPR-induced DNA breaks

High-content CRISPR screening

All-in-one AAV-delivered epigenome-editing platform: proof-of-concept and therapeutic implications for neurodegenerative disorders

CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector

CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions

Droplet-based functional CRISPR screening of cell–cell interactions by SPEAC-seq

Long Read Sequencing reveals transgene concatemerization and backbone integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes

Transcriptional linkage analysis with in vivo AAV-Perturb-seq

High-content imaging-based pooled CRISPR screens in mammalian cells